These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9464464)

  • 1. BIBP3226 inhibits neuropeptide Y and pancreatic polypeptide potentiated neurogenic vasoconstriction.
    Barrios VE; Nelson AG; Toombs CF
    Life Sci; 1998; 62(6):525-32. PubMed ID: 9464464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP 3226.
    Lundberg JM; Modin A
    Br J Pharmacol; 1995 Dec; 116(7):2971-82. PubMed ID: 8680732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropeptide Y2 receptors are involved in enhanced neurogenic vasoconstriction in spontaneously hypertensive rats.
    Gradin KA; Buus CL; Li JY; Frøbert O; Simonsen U
    Br J Pharmacol; 2006 Jul; 148(5):703-13. PubMed ID: 16715120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuropeptide Y (NPY) and peptide YY (PYY) effects in the epididymis of the guinea-pig: evidence of a pre-junctional PYY-selective receptor.
    Haynes JM; Hill SJ; Selbie LA
    Br J Pharmacol; 1997 Dec; 122(7):1530-6. PubMed ID: 9421306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for involvement of neuropeptide Y receptors in the regulation of food intake: studies with Y1-selective antagonist BIBP3226.
    Kask A; Rägo L; Harro J
    Br J Pharmacol; 1998 Aug; 124(7):1507-15. PubMed ID: 9723965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dissociation of potentiation of Leu31 Pro34 neuropeptide Y on adrenergic and purinergic transmission in isolated canine splenic artery.
    Yang XP; Chiba S
    Jpn J Pharmacol; 2000 Jul; 83(3):197-205. PubMed ID: 10952068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of [Leu31,Pro34]NPY-sensitive, BIBP3226-insensitive [125I]PYY(3-36) binding sites in rat brain: possible relationship to Y5 NPY receptors.
    Widdowson PS; Buckingham R; Williams G
    Brain Res; 1997 Dec; 778(1):242-50. PubMed ID: 9462897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropeptide Y accounts for sympathetic vasoconstriction in guinea-pig vena cava: evidence using BIBP 3226 and 3435.
    Malmstrom RE; Lundberg JM
    Eur J Pharmacol; 1995 Dec; 294(2-3):661-8. PubMed ID: 8750731
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective inhibition of neuropeptide Y Y1 receptors by BIBP3226 in rat and human epithelial preparations.
    Tough IR; Cox HM
    Eur J Pharmacol; 1996 Aug; 310(1):55-60. PubMed ID: 8880067
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuropeptide Y Y1 receptor blockade does not alter adrenergic nerve responses of the rat tail artery.
    Duckles SP; Adner M; Edvinsson L; Krause DN
    Eur J Pharmacol; 1997 Dec; 340(1):75-9. PubMed ID: 9527509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of neuropeptide Y (NPY) receptors in human cerebral arteries with selective agonists and the new Y1 antagonist BIBP 3226.
    Abounader R; Villemure JG; Hamel E
    Br J Pharmacol; 1995 Oct; 116(4):2245-50. PubMed ID: 8564255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The non-peptide neuropeptide Y Y1 receptor antagonist BIBP3226 blocks the [Leu31,Pro34]neuropeptide Y-induced modulation of alpha 2-adrenoceptors in the nucleus tractus solitarii of the rat.
    Yang SN; Finnman UB; Fuxe K
    Neuroreport; 1996 Nov; 7(15-17):2701-5. PubMed ID: 8981451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the receptor response for the neuropeptide Y-evoked suppression of parasympathetically-mediated contractions in the guinea pig trachea.
    Grundemar L
    Regul Pept; 1997 Aug; 71(2):97-101. PubMed ID: 9416991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct evidence for the role of neuropeptide Y in sympathetic nerve stimulation-induced vasoconstriction.
    Han S; Yang CL; Chen X; Naes L; Cox BF; Westfall T
    Am J Physiol; 1998 Jan; 274(1):H290-4. PubMed ID: 9458879
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of neuropeptide Y on the sympathetic contraction of the rabbit central ear artery during cooling.
    García-Villalón AL; Padilla J; Fernández N; Monge L; Martínez MA; Gómez B; Diéguez G
    Pflugers Arch; 2000 Aug; 440(4):548-55. PubMed ID: 10958338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuropeptide Y-mediated constriction and dilation in rat middle cerebral arteries.
    You J; Edvinsson L; Bryan RM
    J Cereb Blood Flow Metab; 2001 Jan; 21(1):77-84. PubMed ID: 11149671
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The dog saphenous vein: a sensitive and selective preparation for the Y2 receptor of neuropeptide Y.
    Pheng LH; Fournier A; Dumont Y; Quirion R; Regoli D
    Eur J Pharmacol; 1997 May; 327(2-3):163-7. PubMed ID: 9200555
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticonvulsant properties of BIBP3226, a non-peptide selective antagonist at neuropeptide Y Y1 receptors.
    Gariboldi M; Conti M; Cavaleri D; Samanin R; Vezzani A
    Eur J Neurosci; 1998 Feb; 10(2):757-9. PubMed ID: 9749738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of the neuropeptide Y (NPY)-receptor antagonist BIBP3226 on vascular NPY-receptors with different ligand requirements.
    Grundemar L; Ekelund M
    Pharmacol Toxicol; 1996 Nov; 79(5):266-9. PubMed ID: 8936561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence that the inhibition of luteinizing hormone secretion exerted by central administration of neuropeptide Y (NPY) in the rat is predominantly mediated by the NPY-Y5 receptor subtype.
    Raposinho PD; Broqua P; Pierroz DD; Hayward A; Dumont Y; Quirion R; Junien JL; Aubert ML
    Endocrinology; 1999 Sep; 140(9):4046-55. PubMed ID: 10465275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.